Innoviva (INVA) Capital Expenditures (QoQ) (2010 - 2022)
Innoviva (INVA) Capital Expenditures (QoQ) (2010 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 153.85% |
| Jun 30, 2022 | 44.44% |
| Mar 31, 2020 | 8.33% |
| Dec 31, 2016 | -88.43% |
| Sep 30, 2016 | 2,925.00% |
| Mar 31, 2015 | -95.49% |
| Jun 30, 2014 | -165.68% |
| Mar 31, 2014 | 51.83% |
| Dec 31, 2013 | 352.12% |
| Sep 30, 2013 | -65.85% |
| Jun 30, 2013 | -6.62% |
| Mar 31, 2013 | 183.52% |
| Dec 31, 2012 | -53.97% |
| Sep 30, 2012 | -13.96% |
| Jun 30, 2012 | -40.25% |
| Mar 31, 2012 | 21.88% |
| Dec 31, 2011 | 2,362.50% |
| Sep 30, 2011 | -102.89% |
| Jun 30, 2011 | 0.07% |
| Mar 31, 2011 | 140.17% |